Caricamento...
Steroid-refractory immune related hepatitis may hide viral re-activation
Cancer immunotherapy has become a stronghold in modern oncology. Immune checkpoint inhibitors, in particular anti-PD-1 and anti-PD-L1 antibodies, are approved for the treatment of several solid cancers. In the near future, an increasing number of patients will be eligible for immunotherapy. Therefor...
Salvato in:
| Pubblicato in: | Future Sci OA |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Future Science Ltd
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7668132/ https://ncbi.nlm.nih.gov/pubmed/33235808 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2144/fsoa-2020-0056 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|